Evan David Seigerman's Stock Ratings

BMO Capital Analyst

Evan David Seigerman is an analyst at BMO Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

27.3%

Smart Score

70%

Overall Average Return Percentile

86th

Number of Ratings

24
Buy NowGet Alert
05/03/2024AMGNBuy Now
Amgen
$319.0411.27%$336 → $355MaintainsOutperformGet Alert
05/02/2024PFEBuy Now
Pfizer
$28.8025%$33 → $36ReiteratesOutperform → OutperformGet Alert
04/29/2024ABBVBuy Now
AbbVie
$163.899.83%$195 → $180MaintainsOutperformGet Alert
04/12/2024NVOBuy Now
Novo Nordisk
$134.2621.41% → $163Initiates → OutperformGet Alert
02/05/2024REGNBuy Now
Regeneron Pharmaceuticals
$980.2010.39%$1055 → $1082MaintainsOutperformGet Alert
02/05/2024ABBVBuy Now
AbbVie
$163.8918.98%$187 → $195MaintainsOutperformGet Alert
12/19/2023AMGNBuy Now
Amgen
$319.042.18%$286 → $326UpgradeMarket Perform → OutperformGet Alert
10/27/2023MRKBuy Now
Merck & Co
$132.00— → $132UpgradeMarket Perform → OutperformGet Alert
10/16/2023PFEBuy Now
Pfizer
$28.8014.58%$44 → $33MaintainsOutperformGet Alert
10/06/2023MRTXBuy Now
Mirati Therapeutics
——$31 → $72MaintainsMarket PerformGet Alert
10/03/2023GPCRBuy Now
Structure Therapeutics
$36.07130.11%$40 → $83MaintainsOutperformGet Alert
09/28/2023MORFBuy Now
Morphic Holding
$30.2372.01%$106 → $52MaintainsOutperformGet Alert
08/21/2023REGNBuy Now
Regeneron Pharmaceuticals
$980.200.49%$960 → $985MaintainsOutperformGet Alert
08/09/2023MRTXBuy Now
Mirati Therapeutics
——$40 → $31MaintainsMarket PerformGet Alert
08/02/2023PFEBuy Now
Pfizer
$28.8052.78%$45 → $44MaintainsOutperformGet Alert
05/25/2023MRTXBuy Now
Mirati Therapeutics
——$50 → $40MaintainsMarket PerformGet Alert
05/15/2023CADLBuy Now
Candel Therapeutics
$14.06-78.66%$9 → $3MaintainsOutperformGet Alert
04/26/2023MORFBuy Now
Morphic Holding
$30.23250.65%$83 → $106MaintainsOutperformGet Alert
03/24/2023REGNBuy Now
Regeneron Pharmaceuticals
$980.206.1%$1025 → $1040MaintainsOutperformGet Alert
03/01/2023MRTXBuy Now
Mirati Therapeutics
——$59 → $50MaintainsMarket PerformGet Alert
02/01/2023PFEBuy Now
Pfizer
$28.8084.03%$55 → $53MaintainsOutperformGet Alert
02/01/2023AMGNBuy Now
Amgen
$319.04-20.7%$276 → $253MaintainsMarket PerformGet Alert
12/12/2022REPLBuy Now
Replimune Group
$6.81927.9%$40 → $70MaintainsOutperformGet Alert
09/06/2022LLYBuy Now
Eli Lilly
$788.00-49.75%$369 → $396MaintainsOutperformGet Alert